Can you identify the latest developments related to the treatment of blood cancers? Test your knowledge.
Can you identify the latest developments related to the treatment of blood cancers? Test your knowledge.
Correct Answer and Next Question
ANSWER: B. Increased significantly
Correct Answer and Next Question
ANSWER: D. All of the above
Correct Answer and Next Question
Answer: A. Has been approved by the FDA for selected applications in treating blood cancer
Correct Answer and Next Question
ANSWER: C. Side effects tend to be more severe than with standard therapy
Correct Answer and Next Question
ANSWER: B. Adult Hodgkin lymphoma
Correct Answer and Next Question
ANSWER: B. Home care
Correct Answer and Next Question
ANSWER: D. All of the above
Correct Answer and Next Question
ANSWER: C. A patient is diagnosed with non-Hodgkin lymphoma: 66,769 people diagnosed with non-Hodgkin lymphoma in 2104 --the most recent year for which numbers are available-versus 8,581 with Hodgkin lymphoma. Deaths: 20,387 from non-Hodgkin lymphoma; 1,077 from Hodgkin lymphoma).
Correct Answer and Next Question
ANSWER: C. 75%
Correct Answer and Next Question
ANSWER: A. Acute myeloid leukemia (AML)
Correct Answer and Next Question
ANSWER: D. Both A and B
ANSWER: D. All of the above
Sources: Unless otherwise noted, information was taken from public domains such as the National Cancer Institute and the CDC.
Microplastics, Diet and More: What’s Causing Early-Onset Cancer?
March 18th 2025In a February 2025 Time magazine cover story, Jamie Ducharme reports on this atypical and disquieting trend. Ducharme cites a 79% increase in early-onset cancer diagnoses and a 28% increase in cancer-related deaths in this age group from 1990 to 2019.
Read More
Using the 'Pathway' Approach to Shorten the Time Between Cancer Diagnosis and Treatment
November 16th 2022In this episode of Tuning In to the C-Suite, Briana Contreras, editor with Managed Healthcare Executive spoke with Dr. Yuri Fesko, oncologist and vice president of Medical Affairs at Quest Diagnostics. In the conversation, Dr. Fesko addressed the ongoing issue of long gaps of times between receiving a diagnosis for a type of cancer and finally getting the treatment for it. Dr. Fesko shared the benefits a number of sectors receive when treating patients sooner and the steps to get there.
Listen
CIBMTR Ranks Cedars-Sinai Cancer Among Top Transplant Programs in the U.S.
February 9th 2025Cedars-Sinai was one of 12 among 172 adult transplant centers in the U.S. with a one-year patient post-transplant survival rate above the expected outcome. In 2024, the survival rate for Cedars-Sinai was 90% versus the expected rate of 68% to 83%.
Read More